Corona virus disease 2019 (COVID-19) antibody seroprevalence of the medical staff in the hospital with cluster of COVID-19.

Long-term follow-up of corona virus disease 2019 (COVID-19) antibody seroprevalence in the cohort of employees at hospitals with or without cluster of COVID-19. - Long-term follow-up of COVID-19 antibody seroprevalence in the cohort of medical staff.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040453

Enrollment

2500

Registered

2020-05-25

Start date

2020-05-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Employee of Osaka Police Hospital and Daini Osaka Police Hospital at May 2020. Person who received regular medical checkup.

Exclusion criteria

Exclusion criteria: Person who don't want to participate the study

Design outcomes

Primary

Measure	Time frame
Total number of COVID-19, including those infections that might have been missed (include asymptomatic cases)	—

Secondary

Measure	Time frame
Incidence of seroconversion in high-risk population (working in hospital with cluster, job, and exposure to COVID-19). Timeline of seroconversion. Development of herd immunity.	—

Countries

Japan

Contacts

Public ContactAtsushi Ogata

Daini Osaka Police Hospital Departmrny of Internal Medeicine

a24ogata@icloud.com06-6773-7111

Outcome results